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Endothelial cells respond to blood vessel injury by the acute release of pro-coagulant 
von-Willebrand factor (VWF) that is stored in unique secretory granules called 
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Weibel-Palade bodies (WPBs). Stimulated WPB exocytosis critically depends on the 
proper recruitment of WPBs to the plasma membrane but factors involved in WPB-
plasma membrane tethering are not known. Here we identify Munc13-4, a protein 
mutated in familial hemophagocytic lymphohistiocytosis 3 (FHL3), as a WPB 
tethering factor. Munc13-4 promotes histamine-evoked WPB exocytosis, it is present 
on WPBs, and secretagogue stimulation triggers an increased recruitment of 
Munc13-4 to WPBs and a clustering of Munc13-4 at sites of WPB-plasma membrane 
contact. We also identify the S100A10 subunit of the annexin A2 (AnxA2)-S100A10 
protein complex as a novel Munc13-4 interactor and show that AnxA2-S100A10 
participates in recruiting Munc13-4 to WPB fusion sites. These findings indicate that 
Munc13-4 supports acute WPB exocytosis by tethering WPBs to the plasma 




Weibel-Palade bodies (WPBs) are unique secretory organelles of endothelial cells 
that serve as storage granules for important regulators of vascular homeostasis. 
Factors that are stored in WPBs for acute release on demand include the coagulant 
glycoprotein von-Willebrand factor (VWF) and the leukocyte receptor P-selectin (for 
review see (Sadler, 1998; Wagner and Frenette, 2008)). WPBs have an elongated 
shape that is dictated by the tight packaging of their major cargo, VWF. They form at 
the trans-Golgi network and are then transported along microtubules towards the cell 
periphery where they are anchored at the actin cytoskeleton for final maturation (for 
review see (Nightingale and Cutler, 2013; Valentijn and Eikenboom, 2013)). 
Exocytosis of the fully matured WPBs is evoked by a varied set of secretagogues 
such as histamine and thrombin that function by eliciting intracellular Ca2+-signals, or 
epinephrin and vasopressin that elevate intracellular cAMP (for review see (Datta 
and Ewenstein, 2001; Nightingale and Cutler, 2013)). Typically, acute WPB secretion 
is initiated following blood vessel injury or local inflammatory activation. It results in a 
marked change of endothelial surface properties, rapidly transforming the anti-
adhesive surface of resting endothelial cells, which supports the unrestricted 
circulation of blood cells, to an adhesive one capable of capturing platelets and 
leukocytes. Thus, controlled WPB exocytosis serves an important role in regulating 
blood vessel homeostasis. 
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Several factors involved in WPB maturation and exocytosis have been described. 
They include the Rab GTPases Rab3, Rab15 and Rab27a and some of their 
effectors (Knop et al., 2004; Nightingale et al., 2009; Bierings et al., 2012; van 
Hooren et al., 2012; Zografou et al., 2012). Rab27a is of particular interest as it is a 
specific marker for mature WPBs and is also found on other lysosome-related 
organelles such as melanosomes that share certain properties with WPBs (for review 
see (Marks et al., 2013)). Rab27a is involved in anchoring maturing WPBs at the 
cortical actin cytoskeleton via a tripartite complex consisting of Rab27a, the Rab27a 
effector MyRIP and myosin Va (Nightingale et al., 2009; Rojo Pulido et al., 2011b; 
Conte et al., 2016). However, Rab27a has also been shown to serve as a positive 
regulator of stimulated WPB secretion, in this case exerting its role via another 
effector, the synaptotagmin-like protein Slp4a (Bierings et al., 2012). Thus, Rab27a 
appears to fulfill several functions in WPB exocytosis with its activity being controlled 
by interaction with MyRIP and Slp4a, respectively, and possibly other effectors not 
yet identified. 
 
Once WPBs are committed to exocytosis, the actual fusion reaction is mediated by 
one or several different SNARE complexes. WPB-associated VAMP3 and plasma 
membrane-localized syntaxin-4 and SNAP-23 form a trans-SNARE complex that 
mediates Ca2+-evoked WPB exocytosis and possibly functions in conjunction with 
accessory proteins such as StxBP1 and StxBP5 (Munc18-1 and -5) (Matsushita et 
al., 2003; Rojo Pulido et al., 2011a; van Breevoort et al., 2012; Breevoort et al., 
2014). However, it is unknown how the cortically anchored WPBs are transferred to 
the fusion-mediating SNARE machinery following secretagogue stimulation and 
whether a plasma membrane-tethered WPB intermediate is formed in the course of 
acute WPB exocytosis. 
 
To identify endothelial cell components involved in a plasma membrane tethering of 
WPBs, we focused on Munc13 proteins that are thought to function as 
tethering/priming factors in other Ca2+-dependent exocytotic events (for review see 
(James and Martin, 2013)). We show here that two Munc13 isoforms, Munc13-2 and 
Munc13-4 are expressed in endothelial cells. One of them, the Rab27a effector 
Munc13-4 localizes to WPBs and stimulates WPB exocytosis, however 
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independently of its interaction with Rab27a. Histamine stimulation triggers a 
clustering of Munc13-4 at sites of WPB-plasma membrane contact that is mediated 
by the terminal C2 domains of the protein. In search of novel interactors of these C2 
domains we identify the S100A10 subunit of the AnxA2-S100A10 complex. AnxA2-
S100A10 is recruited to the endothelial plasma membrane following histamine 
stimulation and participates in the formation and/or stabilization of Munc13-4 clusters 
at WPB fusion sites. Our data indicate that Munc13-4 tethers fusion-competent 
WPBs at the plasma membrane via an interaction with the S100A10 subunit of 




Munc13-4 is recruited to WPBs in a Rab27a-independent manner 
To probe for the expression of different Munc13 isoforms in primary human 
endothelial cells (HUVEC), we carried out a comprehensive Western blot screen 
using a panel of Munc13 antibodies. In these experiments, mouse brain and lung 
lysates from wild-type and Munc13 knock-out mice served as positive and negative 
controls for antibody specificity. The blots revealed that Munc13-2 and Munc13-4 
show significant expression, whereas Munc13-1 and Munc13-3 are expressed at 
very low levels or not at all (Fig. 1a-d). These findings were corroborated by RT-PCR 
analysis (Fig. 1e) and are in line with a previous report on the expression of Munc13-
4 in HUVEC (Zografou et al., 2012). 
 
In our next experiments we concentrated on Munc13-4 that had been implicated in 
other regulated exocytosis events in non-neuronal cells, including the 
ATP/VEGF/bFGF-triggered release of VWF from endothelial cells (Zografou et al., 
2012; James and Martin, 2013). We first established by immunofluorescence staining 
that endogenous Munc13-4 is present on WPBs (Fig. 1f). Different fluorescent 
protein (FP)-tagged Munc13-4 constructs (GFP or YFP) showed the same WPB 
localization (Fig. 2) and were then used to record the distribution of Munc13-4 in live 
cells. Because some cytosolic and/or membrane fluorescence was observed in the 
Munc13-4 staining, the contribution of plasma membrane-associated Munc13-4 to 
this staining was analyzed directly by employing total internal reflection fluorescence 
(TIRF) microscopy, which only records signals from fluorophores excited within 100 
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to 200 nm of the plasma membrane at the glass interface. This revealed that 
Munc13-4, in addition to localizing to peripheral WPBs residing in the TIRF field, also 
showed some general colocalization with the plasma membrane marker PLC-PHD, 
encoding the PI(4,5)P2-binding domain of phospholipase C (Fig. 2b). As Munc13-4 
is a known Rab27a effector and Rab27a is highly enriched on WPBs, we analyzed 
whether Rab27a recruits Munc13-4 to WPBs. To this end, we recorded the 
localization of a Munc13-4 mutant lacking the Rab27a binding motif, which had been 
previously identified to encompass residues 280-285 (Elstak et al., 2011). 
Interestingly, this Munc13-4(280-285) mutant still localized to WPBs, indicating that 
Rab27a is not required for the WPB association of Munc13-4 (Fig. 2c). This was 
corroborated by knockdown experiments revealing that depletion of Rab27a has no 
effect on the WPB localization of Munc13-4 (Fig. 2d; see Fig. S1a for Rab27a 
knockdown). WPBs in Rab27a-depleted cells show a less peripheral and more 
perinuclear distribution. This has been reported before and is caused by loss of 
peripheral anchorage at the cortical cytoskeleton mediated by the 
Rab27a/MyRIP/moysinVa complex (Nightingale et al., 2009; Rojo Pulido et al., 
2011b). When quantified, Munc13-4 colocalized with at least 75% of all WPBs of a 
cell, regardless of whether Rab27a was present or not. Similarly, the Rab27a 
binding-deficient mutant Munc13-4(280-285) also colocalized with about 75% of all 
cellular WPBs (Fig. S1b). 
 
To identify sequences in Munc13-4 that mediate WPB association, we next employed 
a series of other mutant Munc13-4 constructs and recorded their distribution in 
HUVEC (for schematic illustrations of the domain structure of Munc13-4, see Fig. 3). 
These analyses revealed that the terminal C2 domains are dispensable but that 
sequences in the Munc homology domains (MHD) 1 and 2 are essential for WPB 
association of Munc13-4 (Fig. 3; Fig. S2 for quantification of the colocalization). Thus, 
while Rab27a does not participate in targeting Munc13-4 to WPBs, the MHD1/2 
region is of critical importance for mediating the WPB association of Munc13-4, 





Munc13-4 supports histamine-induced WPB exocytosis independently of 
Rab27a 
Munc13-4 is associated with WPBs and is involved in other regulated secretory 
events, e.g. the Ca2+-stimulated exocytosis of dense-core granules in mast cells 
(Neeft et al., 2005) and the ATP/VEGF/bFGF-triggered release of VWF from 
endothelial cells (Zografou et al., 2012). Thus, we next analyzed whether Munc13-4 
is functionally involved in histamine-evoked and Ca2+-dependent WPB exocytosis in 
HUVEC. For this purpose, we depleted endogenous Munc13-4 by siRNA (Fig. 4a) 
and assessed the effect on histamine-stimulated WPB exocytosis by quantifying the 
amount of VWF released into the cell culture supernatant. While knockdown of 
Munc13-4 had no significant effect on total cellular VWF levels (Fig. S3) and basal 
VWF secretion, it significantly reduced the histamine-triggered release of VWF (Fig. 
4b). To verify the specificity of the knockdown effect, we generated a siRNA-
insensitive wildtype YFP-Munc13-4 construct that was expressed in siRNA-
transfected cells. This construct fully restored histamine-evoked VWF secretion, 
confirming that Munc13-4 functions as a positive regulator in Ca2+-dependent WPB 
exocytosis. We then assessed whether an interaction with Rab27a is required for the 
activity of Munc13-4 in WPB exocytosis. Therefore, we expressed in the siRNA-
treated cells a siRNA-insensitive version of the Munc13-4(280-285) mutant deficient 
in binding Rab27a. This mutant also efficiently restored histamine-evoked secretion 
in Munc13-4-depleted cells (Fig. 4b). Thus, Munc13-4 is a positive regulator of Ca2+-
dependent WPB exocytosis and this function does not depend on Rab27a binding. 
 
Munc13-4 is recruited to membrane-associated WPBs following secretagogue 
stimulation 
We next analyzed whether the intracellular distribution of Munc13-4 is affected by 
secretagogue stimulation of HUVEC and recorded the dynamic localization of FP-
tagged Munc13-4 constructs in histamine-stimulated HUVEC by live confocal and 
TIRF microscopy. A quantitative analysis of the respective fluorescence images 
revealed that histamine triggers an increase of Munc13-4 at WPBs, including those 
residing in the cell periphery (Fig. 5a). To relate the stimulation-induced enrichment 
of Munc13-4 at peripheral, possibly plasma membrane-tethered WPBs to the actual 
sites of WPB docking and fusion, we coexpressed YFP-Munc13-4 with VWF-RFP, 
which served as a WPB marker. Sites of WPB exocytosis can thus be easily 
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identified by a collapse of the VWF-RFP-labelled rod-like WPB structure into a round 
spot that can be recorded with high spatial and temporal resolution by TIRF 
microscopy. Analyses of fusing WPBs revealed that the YFP-Munc13-4 fluorescence, 
after an initial increase at the WPB before fusion, rapidly disappears after fusion, i.e. 
when the elongated VWF-RFP-positive WPB structure collapses into a bright fusion 
spot (Fig. 5b, c; Suppl. video Fig5video01). Externalized VWF-RFP, on the other 
hand, remains present as a round spot at the fusion site for a considerable length of 
time, probably because large VWF multimers are trapped at the extracellular matrix 
on the coverslip. 
 
Next, live-cell TIRF microscopy was employed to analyze whether histamine 
stimulation also affects the distribution of YFP-Munc13-4 at the plasma membrane 
prior to or at the time of the fusion event. Figure 6a shows that the relatively 
homogeneous plasma membrane signal of Munc13-4, which is seen in addition to 
the WPB staining in resting cells (see also Fig. 2b), becomes concentrated in more 
distinct foci following histamine treatment. In many cases, these foci colocalized with 
VWF-RFP-labelled WPBs that were detectable in the TIRF field and eventually 
underwent fusion (Fig. 6a; Suppl. Video Fig6video02). To better describe the 
dynamic nature of the FP-Munc13-4 foci, TIRF recordings were analyzed using an 
object detection algorithm that identifies bright objects of a size range covering the 
dimensions of WPBs (MorphoQuant, see Methods for details (Schuberth et al., 
2015)). The number of Munc13-4-positive objects most likely reflecting Munc13-4 foci 
tethering WPBs at the plasma membrane increased sharply following histamine 
stimulation and then decreased again with slower kinetics (Fig. 6b). The decrease 
most likely results from a loss of Munc13-4 from sites of WPB fusion and the diffusion 
of Munc13-4 in the membrane (see also Fig. 5b, c). It should be noted that not all 
YFP-Munc13-4-positive foci colocalized with VWF-RFP-labelled WPBs. A 
considerable number appeared at sites where no VWF-RFP signal was visible in the 
TIRF field. These might represent tethering sites of older WPBs not labelled with the 
transiently expressed VWF-RFP; they might reflect a transient enrichment of 
Munc13-4 at docking sites of other secretory vesicles; and/or they might have arisen 
from an intrinsic Ca2+-induced clustering of membrane-associated Munc13-4. 
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As the data described above indicate a role of Munc13-4 in tethering fusion-
competent WPBs at the plasma membrane, we next employed the object detection 
algorithm together with the expression of Munc13-4 mutants to analyze which 
Munc13-4 domains are required for foci formation at the plasma membrane. These 
experiments revealed that both terminal C2 domains are indispensable for this foci 
formation. Truncations of the C2 domains as well as point mutations affecting Ca2+ 
binding (Boswell et al., 2012) largely abolished the histamine-triggered formation of 
Munc13-4 foci (Fig. 7). As expected from our previous analyses, Rab27a binding was 
not required for foci formation because the characteristic transient foci were also 
observed for the Munc13-4(280-285) mutant (Fig. 7). Together the experiments with 
mutant Munc13-4 variants indicate that the central MUN domain of Munc13-4 targets 
the protein to WPBs, whereas following histamine stimulation, the C2A and C2B 
domains are required for inducing an enrichment of Munc13-4 at WPB-plasma 
membrane fusion sites prior to fusion. 
 
Exocytosis of WPBs can also be induced by cAMP-elevating agents such as 
forskolin, although some differences appear to exist between the Ca2+- and cAMP-
dependent pathways (for review see (Datta and Ewenstein, 2001; Nightingale and 
Cutler, 2013)). Therefore, we analyzed whether the transient Munc13-4 foci can also 
be elicited by forskolin. Interestingly, this was not the case (Fig. S4). 
 
Munc13-4 interacts with the S100A10 subunit of the AnxA2-S100A10 complex 
Given the importance of the C2 domains of Munc13-4 in directing the protein to 
plasma membrane sites where WPB fusions occur, we performed a yeast two-hybrid 
(YTH) screen with the two C2 domains of Munc13-4 as baits. The predominant 
potential interaction partner identified in this screen was S100A10; 42 of the 71 
positive clones obtained in the screen with the C-terminal C2 domain contained the 
complete coding sequence of S100A10 (see Suppl. Information for details). S100A10 
is a member of the EF-hand superfamily of Ca2+-binding proteins (Fig. 8a). It resides 
in a tight heterotetrameric complex with AnxA2, a Ca2+-regulated phospholipid and 
plasma membrane binding protein, and the complex acts as a positive regulator of 
acute WPB exocytosis by a yet unknown mechanism (Knop et al., 2004; Brandherm 
et al., 2013). To confirm the interaction of Munc13-4 with S100A10 and to map their 
respective binding sites, we performed pull-down experiments with recombinantly 
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expressed and purified Munc13-4 and S100A10 derivatives. This revealed that 
S100A10 and Munc13-4 directly interact with one another and that both C2 domains 
of Munc13-4 bind S100A10 (Fig. 8b). We also obtained quantitative binding 
parameters by surface plasmon resonance (KD=0.45 M, Fig. S5). Pull-down 
experiments with different S100A10 mutants revealed that in S100A10 the binding 
site for Munc13-4 resides in the very C-terminal six residues (amino acid 91-96) (Fig. 
8c). This region is dispensable for AnxA2 binding (Kube et al., 1992), indicating that 
S100A10 can bind simultaneously to AnxA2 and Munc13-4. To test whether tripartite 
AnxA2/S100A10/Munc13-4 complexes do form in endothelial cells, we carried out co-
immunoprecipitation (co-IP) experiments. These revealed a significant co-IP of all 
three proteins from HUVEC lysates in the absence of Ca2+ (Fig. 8d; quantification of 
co-IP results for Munc13-4 and S100A10 in Fig. 8e). Thus, tripartite complexes of 
S100A10 binding both AnxA2 and Munc13-4 do form in HUVEC and Munc13-4 is 
recruited to these complexes via its C2 domains. 
 
Given the likely tethering function of Munc13-4 in WPB exocytosis, we also assessed 
whether AnxA2-S100A10 participates in a Munc13-4-mediated tethering of WPBs. A 
prerequisite for such a function would be a histamine-evoked and thus Ca2+-induced 
recruitment of AnxA2-S100A10 to the plasma membrane because the majority of 
AnxA2-S100A10 resides in the cytoplasm of non-stimulated HUVEC (Knop et al., 
2004). As revealed by live-cell TIRF microscopy, histamine stimulation leads to a 
marked increase of FP-tagged AnxA2 and S100A10 at the plasma membrane, most 
likely due to a membrane translocation from the cytosol (Fig. S6a, b; see also Suppl. 
videos FigS6video03 and FigS6video04). Some of the translocated S100A10 also 
becomes enriched at the stimulation-induced Munc13-4 foci that occur at sites of 
WPB tethering and fusion (Fig. S6c; see also Suppl. video FigS6video05). 
 
Next, we analyzed a potential role of AnxA2-S100A10 in the formation and/or 
stabilization of the Munc13-4 tethers. Therefore, we depleted HUVEC of AnxA2 and 
S100A10 by siRNA knockdown and determined the level of Munc13-4 at WPB 
docking/fusion sites by recording histamine-induced changes in Munc13-4-mKate 
fluorescence in live HUVEC using TIRF microscopy. As expected, control siRNA-
transfected cells show a histamine-triggered increase of WPB-associated Munc13-4-
mKate fluorescence that decreases after fusion (Fig. 9a). This transient increase is 
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markedly reduced following AnxA2-S100A10 knockdown (Fig. 9a, b) indicative of a 
function of AnxA2-S100A10 in recruiting Munc13-4 to WPB-plasma membrane 
contact sites or stabilizing Munc13-4 clusters at these sites.  
 
Finally, we determined whether the interaction of Munc13-4 with AnxA2-S100A10 is 
functionally relevant for WPB exocytosis. Therefore, HUVEC were depleted of 
Munc13-4 or S100A10, or of Munc13-4 plus S100A10 in a double knockdown 
approach. We then assessed the effects on histamine-evoked WPB exocytosis by 
quantifying the amount of secreted VWF. The results confirmed the reduction of 
histamine-stimulated VWF secretion by Munc13-4 (see Fig. 4) or S100A10 depletion 
(Knop et al., 2004). Importantly, the simultaneous knockdown of Munc13-4 and 
S100A10 had no additional inhibitory effect (Fig. 9c; see Fig. S7 for knockdown 
efficiency). This suggests that the proteins function in a common pathway and 
supports the notion that a tripartite Munc13-4/S100A10/AnxA2 complex is a positive 
regulator of WPB exocytosis. 
Discussion 
 
WPBs are secretory organelles of vascular endothelial cells that serve an important 
role in controlling blood vessel homeostasis. WPB exocytosis exposes the adhesive 
platelet and leukocyte receptors VWF and P-selectin, thereby rapidly converting the 
anti-adhesive endothelial surface to an adhesive one, for example after blood vessel 
injury or local inflammatory activation. Hence, the exocytosis of WPBs has to be 
strictly regulated and can be evoked by secretagogue stimulation and the 
subsequent transient increase in intracellular Ca2+. Although this Ca2+-dependent 
WBP exocytosis is well documented, the Ca2+-sensors and tethering/priming factors 
involved are not known. Here, we identify a novel complex consisting of Munc13-4 
and AnxA2-S100A10 as a positive regulator of Ca2+-evoked WPB exocytosis. 
Munc13-4 is present on WPBs in resting endothelial cells and clusters at sites of 
WPB exocytosis following histamine stimulation. It interacts directly with the S100A10 
subunit of the AnxA2-S100A10 complex, which is recruited to the plasma membrane 
following secretagogue stimulation and facilitates Munc13-4 clustering, and both, 




Munc13-4 functions in regulated exocytosis in different non-neuronal cells, often of 
hematopoietic origin, including mast cells, endothelial cells stimulated with a mixture 
of ATP/VEGF/bFGF and cytotoxic T lymphocytes (Feldmann et al., 2003; Neeft et al., 
2005; Zografou et al., 2012). It has been suggested that the protein acts as a 
tethering and priming factor in granule-plasma membrane interactions, although 
direct evidence for these tethers is still lacking (James and Martin, 2013). Our data 
are in line with a tethering function of Munc13-4 and provide evidence for the 
existence of tethering complexes in endothelial cells as we see an increased FP-
Munc13-4 signal in distinct plasma membrane foci that are induced by secretagogue 
stimulation and coincide with WPB fusion sites. In resting HUVEC, Munc13-4 is 
found on WPBs although a fraction of the protein also resides at the plasma 
membrane and in the cytosol. Histamine stimulation triggers a transient increase at 
and redistribution of Munc13-4 to the foci that most likely represent WPB tethering 
complexes. This redistribution requires the terminal C2 domains, indicating that Ca2+-
binding and/or specific protein or lipid interactions of these C2 domains are relevant 
for the tethering function. As the C2A domain can interact with different syntaxins and 
the C2B domain can bind certain phospholipids (Boswell et al., 2012), these 
interactions, induced by secretagogue-stimulated Ca2+-increase, could trigger or 
assist the enrichment of Munc13-4 at WPB fusion sites. Such interactions are likely 
to occur after complex formation of Munc13-4 with AnxA2-S100A10 following a Ca2+-
dependent translocation of AnxA2-S100A10 to the plasma membrane. In this 
scenario, subsequent SNARE interactions of plasma membrane-docked Munc13-4 
could help stabilize the tether and could also initiate a priming of tethered WPBs 
leading to SNARE-mediated fusion. A function of Munc13-4 in linking tethered WPBs 
to the SNARE fusion machinery is in line with the finding that the C2A domain binds 
syntaxins 2 and 4, which both have been implicated in WPB exocytosis (Matsushita 
et al., 2003; Rojo Pulido et al., 2011a; Boswell et al., 2012). 
 
We show here that histamine stimulation promotes a translocation of cytoplasmic 
AnxA2-S100A10 to the plasma membrane, most likely by inducing Ca2+-dependent 
phospholipid binding in the AnxA2 subunits (Fig. S6). In the resulting membrane-
bound conformation of AnxA2-S100A10, the two AnxA2 subunits likely face the 
membrane through direct interaction with acidic phospholipids, such as PA, PI(4,5)P2 
and/or PS, whereas the S100A10 subunits point towards the cytosol (Menke et al., 
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2005). The S100A10 subunit is then available for additional interactions, and thereby 
the entire complex can serve as a Ca2+-regulated plasma membrane targeting 
module for S100A10 binding proteins. A number of such proteins have been 
described, e.g. the Ca2+-channels TRPV5 and TRPV6, the sodium channel Nav1.6 
and the serotonin 5-HT1B receptor (Okuse et al., 2002; van de Graaf et al., 2003; 
Svenningsson et al., 2006). Here we identify Munc13-4 as a new S100A10 
interaction partner that can use the AnxA2-S100A10 module as a means to trigger 
and/or stabilize a plasma membrane-bound state required for efficient tethering of 
WPBs (see Fig. 9a, b). In this scenario, AnxA2-S100A10 regulates Munc13-4-
mediated tethering, and this function, in turn, is regulated by Ca2+-triggered 
membrane targeting of the AnxA2-S100A10 complex itself. 
 
In other secretory cell types, Munc13-4 function depends on a Rab27a-mediated 
association with secretory granules that are often considered lysosome-related 
(James and Martin, 2013). However and in contrast to secretory events involving 
other lysosome-related organelles, a Rab27a-Munc13-4 interaction is required 
neither for recruiting Munc13-4 to WPBs nor for Munc13-4 to promote WPB 
exocytosis (Fig. 2 and 4). Rather, we identified a sequence towards the C-terminal 
end of the central MUN domain that is indispensable for WPB interaction. The 
different domains in Munc13-4 therefore integrate several interactions crucial for 
efficient WPB exocytosis: (1) A MUN domain-mediated anchoring of Munc13-4 to 
WPBs; (2) a C2 domain-mediated link to AnxA2-S100A10 at the plasma membrane; 
(3) an interaction of Munc13-4 with both syntaxins and certain lipids mediated by its 
C2A and C2B domains, respectively. Thus, the mechanism underlying Munc13-4 
function in endothelial cells appears to be unique as it does not involve an interaction 
with Rab27a. Interestingly, FHL3 patients who carry mutations in Munc13-4 show no 
overt bleeding phenotype, i.e. no severe compromise in VWF secretion. This lack of 
a severe bleeding phenotype is possibly due to the unperturbed cAMP-dependent 
WPB exocytosis (see Fig. S6). Future analysis of FHL3 patients might reveal more 






Materials and methods 
 
Antibodies, plasmids, siRNA, reverse transcriptase-PCR and surface plasmon 
resonance 
The experimental details are described in Supplementary Information. 
 
HUVEC culture and transfection 
Primary human umbilical vein endothelial cells (HUVEC) were either isolated from 
umbilical cord veins as described before (Jaffe et al., 1973) and used as fresh or 
cryoconserved preparations, or purchased as cryoconserved pools (Promocell). Cells 
were maintained in mixed endothelial growth medium (ECGM1, Promocell, mixed 1:1 
with M199, Biochrom, supplemented with 10% FCS, 20 µg/ml gentamycin, 15 µg/ml 
amphotericin B and 100 I.E. Heparin) or endothelial growth medium (ECGM2, 
Promocell; supplemented with 20 µg/ml gentamycin, 15 µg/ml amphotericin B), and 
cultured and transfected as described before (Knop et al., 2004). Nearly confluent 
cells at passages 2-4 were used in all experiments.  
 
Western blot 
For the Western blot detection of Munc13 isoforms in HUVEC, we employed as 
controls postnuclear supernatants from mouse brains or lungs that were prepared by 
homogenization in lysis buffer (320 mM sucrose, 2 mM EDTA, 20 mM HEPES/NaOH 
to pH 7.4) and centrifugation (1000 g for 10 min at 4°C). HUVEC lysates were 
prepared as total lysates by washing a 60 mm plate once with PBS on ice, scratching 
the cells into 40 µl sample buffer (6% (w/v) SDS, 150 mM Tris/HCl pH 6.8, 30% (v/v) 
glycerol, 0.01% (w/v) bromophenol blue, 10% (w/v) DTT) and boiling at 95°C for 10 
min. Samples were subjected to SDS-PAGE in 8% acrylamide gels, transferred to a 
nitrocellulose membrane at 50 mA overnight in Tris-glycine buffer (25 mM Tris, 190 
mM glycine, 20% (v/v) methanol) and blocked for 1 h in TBS containing 0.1% Tween-
20 (TBS-T), 5% milk powder and 5% goat serum. Membranes were incubated with 
the respective primary antibodies overnight and subsequently with the HRP- or IR-
coupled secondary antibodies for 1 h, with extensive washings (TBS-T with 5% milk 
powder) after each antibody incubation. Signals were detected by 
chemiluminescence or using the Odyssey Infrared Imaging System (LI-COR). For 
Western blot detection of S100A10 and AnxA2, we employed standard procedures 
and 10% or 15% SDS-PAGs. 
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VWF secretion assay 
HUVEC were stimulated with 100 µM histamine (Sigma-Aldrich) or 1 M ionomycin 
and the amount of secreted VWF was quantified by ELISA as described before (Rojo 
Pulido et al., 2011b), analyzing three triplicate samples per condition (supernatant of 
unstimulated cells, of stimulated cells, and total lysates). The amount of VWF 
secreted into the cell culture supernatant was then expressed as percentage of total 
VWF content (amount of VWF of all three samples summed up, i.e. supernatant of 
non-stimulated plus supernatant of stimulated cells plus remaining total lysate). This 
analysis allowed to control for differences in total VWF content between each 
replicate and each condition. 
 
Yeast two-hybrid screening 
Bait vectors encoding the LexA DNA binding domain in frame with rat Munc13-4 
(GenBank accession number AF159356 (Koch et al., 2000); residues 1-303 (N-
terminal C2) or 888-1088 (C-terminal C2) were constructed in pLexN (Vojtek et al., 
1993; Betz et al., 1997). Yeast two-hybrid screens using a rat lung cDNA 
MATCHMAKER prey library in pACT2 (Clontech) were performed as described 
(Fields and Song, 1989; Betz et al., 1997). 
The YTH screen with the N-terminal C2 domain of Munc13-4 yielded 78 positive 
clones from 31 million double transformants. Of these, 37 encoded the full-length 
cardiac Troponin 1 (Tnni3), and 18 encoded the GABAA-receptor associated protein 
Gabarap. All 18 Gabarap clones encoded the complete C-terminus of the protein, but 
lacked the codons for the first 10 (11 clones) or 43 N-terminal residues (7 clones). 
Less frequently isolated positive prey clones (each <5 % of the total) encoded 
fragments of Rgs3, Ulc1, Ndn, and Rps18. The YTH screen with the C-terminal C2 
domain of Munc13-4 yielded 71 positive clones from 170 million double 
transformants. Of these, 42 contained the complete coding sequence of S100A10, 
and 12 encoded the complete coding sequence of Sorting Nexin 5 (Snx5). Less 
frequently isolated positive prey clones (each <5 % of the total) encoded fragments of 






For the immunoprecipitation of Munc13-4, we employed rabbit polyclonal anti-
Munc13-4 (Proteintech or SantaCruz, sc-50465) and, as control, non-specific rabbit 
IgGs that were coupled to anti-rabbit IgG Dynabeads (Invitrogen) or Protein A-
Agarose beads (SantaCruz). HUVEC were washed twice with ice-cold PBS, 
harvested with a cell scraper and collected by low speed centrifugation. The cell 
pellets were resuspended in ice-cold lysis buffer (20 mM HEPES pH 7.4, 150 mM 
NaCl, 0.5% NP-40, Complete EDTA-free Protease Inhibitor Cocktail, Roche), lysed 
by passage through a 23 gauge needle and post nuclear supernatants (PNS) were 
prepared by centrifugation of the lysates (1,000 x g, 10 min, 4°C). 
Immunoprecipitations were carried out by incubating the PNS with the respective 
beads for 2 h or 4 h at 4°C, and subsequently, the beads were washed three times 
with ice-cold lysis buffer or washing buffer (20 mM Hepes pH 7.4, 500 mM NaCl, 
0.5% NP-40) using a magnetic particle concentrator (Invitrogen) or low speed 
centrifugation. After the last wash, proteins bound to the beads were released by 
resuspending the beads in SDS protein loading buffer [50 mM Tris–HCl pH 6.8, 2% 
(w/v) SDS, 10% (v/v) β-mercaptoethanol, 10% (v/v) glycerol, 0.1% (w/v) 
Bromophenol blue], and analyzed by Western blotting with rabbit and goat polyclonal 
anti-Munc13-4 antibodies, anti-S100A10 and anti-AnxA2 antibodies, and with IR-dye 
coupled secondary antibodies as described above (Western blot). 
 
Expression of His6-tagged Munc13-4 derivatives 
His6-tagged derivatives of Munc13-4 were expressed in E. coli (BL21) following 
overnight induction with 0.1 mM IPTG at 25°C to reduce protein misfolding and 
degradation. Bacteria were harvested by centrifugation and resuspended in lysis 
buffer (40 mM HEPES pH 7.5, 20 mM imidazole, 300 mM NaCl, 1 mM EDTA, 10 mM 
2-Mercaptoethanol, Complete EDTA-free Protease Inhibitor Cocktail, Roche). Cell 
lysis was achieved by four freeze/thaw cycles and six 1 min sonication steps, and 
soluble lysates containing His6-tagged Munc13-4 were obtained by ultracentrifugation 
(100,000 x g, 1 h, 4°C). 
 
Expression and purification of untagged S100A10 
Bacterial expression of S100A10 followed a similar protocol as the one used for His6-
tagged derivatives of Munc13-4 (see above), but treatment with 1 mM IPTG for 4 h at 
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37°C was used for induction of recombinant protein expression, and a modified lysis 
buffer was employed (200 mM Tris/HCl pH 7.5, 200 mM NaCl, 10 mM MgCl2, 1 mM 
NaN3, 2 mM DTT, Complete EDTA-free Protease Inhibitor Cocktail). Different 
protocols were then employed to prepare wild-type S100A10 or the truncated 
S100A10 mutants (residues 1-90, 1-84). Wild-type S100A10 was purified from the 
soluble bacterial lysate by ion exchange chromatography in two consecutive steps 
(modified after (Kube et al., 1992)) using the weak anion exchanger DEAE sephacel 
(Diethylaminoethyl, GE Healthcare; DEAE buffer, 20 mM imidazole pH 7.5, 50 mM 
NaCl, 2 mM DTT, 5 mM EDTA, 0.5 mM EGTA, 1 mM NaN3), and applying the flow-
through to the weak cation exchanger CM52 cellulose (carboxymethyl, Whatman; 
CM buffer 20 mM sodium acetate pH 5.6, 2 mM DTT, 0.5 mM EDTA, 0.5 mM EGTA, 
1 mM NaN3). After extensive washing with CM buffer and CM buffer containing 100 
mM NaCl, wild-type S100A10 was eluted with 500 mM NaCl in CM buffer. 
S100A10(1-90) and S100A10(1-84) could not be eluted from the CM matrix material 
and were purified using a different protocol(Ayala-Sanmartin et al., 2000). Briefly, 
cleared bacterial lysates were first subjected to (NH4)2SO4 precipitation at 50% 
saturation. After centrifugation (50,000 x g, 30 min), the non-precipitated fraction was 
applied to a phenyl sepharose matrix (GE Healthcare) that retained the S100A10 
derivatives. The matrix was washed with loading buffer and bound proteins were 
eluted with decreasing concentrations of (NH4)2SO4 in lysis buffer (50%, 25%, 15% 
and 0% saturation of (NH4)2SO4). The last two fractions containing the S100A10 
derivatives were applied to DEAE sephacel equilibrated in DEAE buffer. The column 
was washed with DEAE buffer containing 100 mM NaCl and proteins were eluted 
with 300 mM NaCl in DEAE buffer. 
 
In vitro binding assay with His6-Munc13-4 variants and S100A10 
Soluble fractions of His6-Munc13-4 or cleared lysates of untransformed BL21 
bacteria as control were incubated with NiNTA beads equilibrated in assay buffer (40 
mM HEPES pH 7.5, 20 mM imidazole, 300 mM NaCl, 0.5 mM EDTA, 10 mM 2-
mercaptoethanol, 1 mM CaCl2) for 15 min at 4°C. After two washings with ten column 
volumes of assay buffer, equal amounts of wild-type or mutant S100A10 dialyzed 
against assay buffer were applied to the column. After several washings with ten 
column volumes of assay buffer, His6-Munc13-4 and potentially interacting S100A10 
were released with elution buffer containing 300 mM imidazole (300 mM imidazole, 
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300 mM NaCl, 1 mM MgCl2, 10 mM 2-mercaptoethanol) in several steps. Samples of 
all steps were run on 15% SDS-PAGs, transferred to nitrocellulose membranes and 
analyzed by probing with anti-penta-Histidine and anti-S100A10 (H21) antibodies as 
described above (Western blot).  
 
Confocal and TIRF microscopy 
Cells were grown on collagen-coated coverslips or chambered slides (Nunc Labtek 
Chambered Coverglass) for 48 h after transfection if not stated otherwise. For 
analysis of fixed cells, samples were treated with 4% PFA (30 min, RT) or methanol 
(10 min, -20°C), permeabilized with 0.1% Triton-X100 (15 min, RT), and mounted in 
Mowiol. Live cells were imaged in medium supplemented with 25 mM HEPES at 
37°C. Confocal imaging employed a Zeiss LSM780 confocal microscope and a Plan-
Apochromat 63x/1.4 oil immersion objective. Confocal videos were recorded at 
different speeds. TIRF imaging was performed with an Olympus IX71 TIRF 
Microscope customized to include a heated incubation chamber, an objective-type 
TIRFM setup from TILL Photonics, a monochromator for epifluorescence excitation, 
and a controller allowing hardware-controlled fast switching between total internal 
reflection fluorescence and epifluorescence (TILL Photonics). Images were acquired 
using a TILL Image QE charge-coupled device camera (TILL Photonics) and 
MetaMorph Software (Molecular Devices). The total internal reflection angle was 
manually adjusted for every experiment. TIRF time-lapse movies were recorded with 
2-5 frames per second. Image analysis was performed in ImageJ. 
 
Stimulation-induced recruitment of Munc13-4 to WPBs 
Stimulation-induced recruitment of Munc13-4 to WPBs was measured in TIRF 
microscopy recordings or confocal sections of cells expressing VWF-RFP or VWF-
GFP and YFP-Munc13-4 or Munc13-4-mKate, respectively. Image stills were 
thresholded in ImageJ to create regions-of-interest (ROIs) for Munc13-4-positive 
WPBs in a cell and to compare mean fluorescence intensities of all ROIs before and 
after stimulation. ROIs were manually inspected to delete those that did not include 
the same WPBs in both frames because the WPBs had moved. Mean fluorescence 
intensities before stimulation were set as 1; the increase after stimulation was 
measured as the n-fold change in mean fluorescence intensities for every individual 
ROI. Mean n-fold changes from all individual ROIs were tested for statistical 
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significance by one-sample t-test from n=323 WPBs and seven independent 
experiments (Fig. 5) and by Mann-Whitney U test from at least n=57 WPBs per 
conditions and at least three independent experiments (Fig. 9b and c).  
 
Automated object detection 
Munc13-4-positive objects were detected in TIRF live recordings before and after 
stimulation using the Matlab-based image-processing algorithm MorphoQuant, which 
was originally developed to detect Golgi structures (Schuberth et al., 2015). 
MorphoQuant is freely available at https://github.com/tischi/MorphoQuant. The 
algorithm detects locally bright large objects of arbitrary shape. The algorithm used a 
top-hat filter with a circular structural element whose radius r1 was defined to include 
a typical WPB (r1 = 15 pixel with 1 pixel ≈ 133 nm). This filter segmented images into 
a foreground image containing Munc13-4-positive objects and a background image 
representing the Munc13-4 at the plasma membrane. Subsequent filtering steps 
improved the distinction between foreground objects and background signal based 
on their relative fluorescence intensity, defined by an adjustable threshold t1 (t1 = 8 
a.u.). The procedure identified Munc13-4-positive bright objects (adjusted by t1) of a 
defined size (adjusted by r1) but otherwise arbitrary shape. We visually confirmed 
that object detection was accurate and that objects showed the typical elongated 
shape of WPBs. Data were prepared in Excel to illustrate the number of Munc13-4-
positive objects and fluorescence of Munc13-4 on objects or non-objects over time. 
 
Quantification of colocalization of Munc13-4 with WPBs 
The fluorescence intensities of VWF were plotted across each WPB using ImageJ. 
The same cross section was plotted for the Munc13-4 fluorescence channel. WPBs 
were counted as Munc13-4-positive if the Munc13-4 fluorescence at the WPB 
fluorescence intensity peak was at least 1.5 times higher than background. At least 
300 WPB from at least three individual experiments were quantified for each 
condition.   
 
Statistical analysis 
Statistical analyses were performed with GraphPad Prism 6 as indicated in the figure 
legends. Significance threshold was P<0.05. We tested for normal distribution with 
the D'Agostino-Pearson omnibus test. When single datasets were not normally 
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distributed, we confirmed the validity of the one-way ANOVA or t-test by non-
parametric Kruskal-Wallis or Mann-Whitney test. Mean values are expressed as 
mean±SEM. In boxplots, boxes extend from 25th to 75th percentile, whiskers extend 
from 10th to 90th percentile, line represents the median and dots indicate outliers. 
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Figure 1. Expression and localization of Munc13 proteins in human endothelial 
cells. 
(a-d) Western blot (IB) detection of Munc13-1 to -4 in two different HUVEC lysates. 
Included are positive (+) and negative controls (-), i.e. mouse brain lysates (Munc13-
1 to -3) or mouse lung lysate (Munc13-4) from wildtype or the respective knockout 
mouse. Calculated molecular masses are: Munc13-1, 193 kDa; Munc13-2, 180 kDa; 
Munc13-3, 250 kDa (migrates at appr. 280kDa in SDS-PAGE(Varoqueaux et al., 
2005); Munc13-4, 123 kDa. VCP (97 kDa) and alpha-tubulin (55 kDa) served as 
loading control. In (a), the weaker band below Munc13-1 most likely corresponds to 
Munc13-2 which shows some cross-reactivity with the anti-Munc13-1 antibody 
(Cooper et al., 2012). The lower band in the HUVEC lysates in panel (c) likely stems 
from an unspecific antibody reaction as it is not seen in the mouse lysates. 
(e) Reverse transcription PCR (RT-PCR) of HUVEC cDNA with primers amplifying 
specific sequences of all human Munc13 proteins (Munc13-1, 243 bp; Munc13-2, 159 
bp; Munc13-3, 168 bp; Munc13-4, 201 bp). 
(f) Confocal section of fixed HUVEC labeled with anti-Munc13-4 and anti-VWF 
antibodies and AlexaFluor488- and AlexaFluor647-conjugated secondary antibodies.  
Arrowheads mark examples of colocalizations of Munc13-4 and VWF on WPBs. 
Scale bar represents 10 µm. 
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Figure 2. Munc13-4 localizes to WPBs and the plasma membrane 
independently of Rab27a. 
(a) Confocal section of fixed HUVEC expressing YFP-Munc13-4 for 48 h and labeled 
with anti-VWF and AlexaFluor568-conjugated secondary antibodies. 
(b) TIRF section of live HUVEC expressing YFP-Munc13-4 and the PI(4,5)P2-binding 
domain PLCδ4-PH-mKate as membrane marker.  
(c) Confocal section of fixed HUVEC expressing GFP-Munc13-4(280-285), a 
mutant incapable of binding Rab27a, and labeled with anti-VWF and AlexaFluor568-
conjugated secondary antibodies. 
(d) Confocal section of fixed HUVEC expressing YFP-Munc13-4 and transfected with 
siRNA against Rab27a (siRab27a) for 48 h. Cells were labeled with anti-VWF and 
AlexaFluor568-conjugated secondary antibodies. 
Arrowheads mark examples of colocalizations of Munc13-4 and VWF on WPBs.  
Scale bars represent 10 µm.  
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Figure 3. Munc13-4 localizes to WPBs via its MHD1/MHD2 region. 
TIRF images of live HUVEC expressing different truncated versions of YFP-Munc13-
4 and VWF-RFP as WPB marker for 48 h. On the right side, the domain structures of 
the respective Munc13-4 mutants lacking either the C2A (aa 109-284), C2B (aa 904-
1047), or parts of the MUN domain (aa 319-901) are shown. The first about hundred 
amino acids of Munc13-4 of unknown structure were omitted for simplicity. MHD1 (aa 
577-677) and MHD2 (aa 788-894) are two regions within the MUN domain with 
conserved sequences in all Munc13 proteins. 
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(a) Munc13-4(543-1090), which lacks the C2A and parts of MUN domain but contains 
the entire region around MHD1/2. 
(b) Munc13-4(1-899), which lacks the C2B but contains the entire MHD1/2 region.  
(c) Munc13-4(285-917), which lacks C2A and C2B. 
(d) Munc13-4(1-780), which is truncated after MHD1 and therefore lacks MHD2-C2B.  
(e) Munc13-4(781-1090), which lacks the entire N-terminal part including MHD1.  
Arrowheads mark examples of colocalizations of Munc13-4 and VWF on WPBs. Note 
that mutants containing the MHD1 and MHD2 regions localize to WPBs, whereas 
those lacking these sequences do not. Scale bars represent 10 µm. 
 
Figure 4. Munc13-4 is required for histamine-induced secretion of VWF. 
(a) HUVEC were treated either with unspecific siRNA as control (siControl) or with 
siRNA targeting Munc13-4 (siMunc13-4), and lysates of the respective cells were 
subjected to Western blot analysis with anti-Munc13-4 antibodies. Probing with anti-
alpha-Tubulin (55 kDa) antibodies served as loading control. Note that endogenous 
Munc13-4 was successfully depleted. 
(b) ELISA-based VWF secretion assay. HUVEC were transfected with siControl or 
Munc13-4 targeting siRNA (siMunc13-4) plus expression vectors encoding YFP 
(control), YFP-Munc13-4 or GFP-Munc13-4(280-285), which were both rendered 
insensitive to the specific Munc13-4 siRNA (see Materials and methods). In each 
case, the amount of VWF secreted into the cell culture supernatant was measured by 
ELISA. Shown are means of at least five independent experiments that were tested 
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for statistical significance by one-way ANOVA with Tukey’s test (ns, not statistically 
significant, * p≤0.05, ** p≤0.01, **** p≤0.0001). Bars represent mean±SEM. The 
numbers of independent experiments n were as follows: siControl + YFP or Munc13-
4, n=8; siControl + 280-285, n=7; siMunc13-4 + YFP or Munc13-4, n=6; siMunc13-4 
+ 280-285, n=5.  
 
Figure 5. Histamine stimulation induces an additional recruitment of Munc13-4 
to WPBs. 
(a) Munc13-4 fluorescence signals increase on WPBs after histamine stimulation. 
Cells expressing YFP-Munc13-4 or Munc13-4-mKate together with VWF-RFP or 
VWF-GFP were stimulated with histamine and imaged by live-cell confocal 
microscopy. Image stills were thresholded in ImageJ to create regions-of-interest 
(ROIs) for Munc13-4-positive WPBs in a cell and to compare mean fluorescence 
intensities of all ROIs shortly before and shortly after stimulation. Mean fluorescence 
intensity before stimulation was set to 1 and the increase after stimulation was 
measured as the n-fold change in mean fluorescence intensity for every individual 
ROIs. Mean n-fold changes from all individual ROIs (a total of n=323 WPBs from at 
least three independent experiments) were tested for statistical significance by one-
sample t-test (**** p≤0.0001). 
(b) Munc13-4 increases and then disappears at WPB during exocytosis. HUVEC 
expressing YFP-Munc13-4 and VWF-RFP were stimulated with 100 µM histamine 
and the fusion of individual WPBs with the plasma membrane was recorded by TIRF 
microscopy. Shown are TIRF sections of a single WPB positive for YFP-Munc13-4 
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and VWF-RFP. The cell was stimulated at t=0 s and fusion of this WPB occurred at 
t=10 s. See also supplementary video Fig5video01. Scale bar represents 1 µm. 
(c) Graph depicting the corresponding mean fluorescence intensities (YFP, RFP) of 
the WPB shown in (b) over time. The YFP-Munc13-4 signature shows a fluorescence 
increase upon stimulation (t=0 s to t=2.5 s), and subsequently a rapid decrease in 
fluorescence that coincides with the formation of a characteristic VWF fusion spot 
(t=10 s to t=11.5s). 
 
Figure 6. Histamine stimulation induces a clustering of Munc13-4 at or close to 
the plasma membrane. 
(a) TIRF sections of live HUVEC expressing YFP-Munc13-4 and VWF-RFP as WPB 
marker and stimulated with 100 µM histamine at t=0 s. Before stimulation, YFP-
Munc13-4 shows a general plasma membrane localization and is present on VWF-
RFP-positive WPBs that reside in the TIRF field (examples marked by filled 
arrowheads). Some YFP-Munc13-4-positive objects that are shaped like WPBs but 
do not contain VWF-RFP can also be weakly seen against the general background 
(examples marked by open arrowheads). Stimulation triggers an additional clustering 
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of Munc13-4 (t=3 s), i.e. the Munc13-4-positive objects become brighter as more 
Munc13-4 is recruited to them (see also Fig. 5 for WPB-associated Munc13-4). WPB 
exocytosis, which is accompanied by the formation of a characteristic VWF-RFP 
fusion spot, leads to a disappearance of the Munc13-4-positive clusters. Arrowheads 
mark examples of Munc13-4-positive objects that colocalize with VWF-RFP and 
disappear following WPB fusion (fusion here occurred between t=3 and t=27 s). 
Scale bar represents 10 µm. See also supplementary video Fig6video02. 
(b) Graph displaying the number of Munc13-4-positive objects over time per cell in 
the TIRF field. 
 
Figure 7. Deletion of C2A or C2B abolishes the stimulation-induced clustering 
of Munc13-4 at the plasma membrane. 
TIRF time-lapse movies of live HUVEC expressing YFP-Munc13-4, Munc13-4-mKate 
or the indicated mutant constructs and VWF-RFP as WPB marker were recorded and 
the obtained images subsequently analyzed by the object detection algorithm 
MorphoQuant. 
(a) Representative graphs showing the number of Munc13-4-positive objects 
detected in the TIRF field of HUVEC stimulated with 100 µM histamine at t=15 s. 
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Cells were transfected with YFP- or mKate-tagged full-length Munc13-4, Munc13-4 
variants with truncated C2 domains, Munc13-4 variants with mutations in the Ca2+-
binding sites of the C2 domains, or Munc13-4(Δ280-285).  Munc13-4(543-1090) lacks 
the C2A domain, Munc13-4(1-899) lacks the C2B domain and Munc13-4(285-917) 
lacks both C2A and C2B (Elstak et al., 2011). Munc13-4(C2A*) carries two point 
mutations in the Ca2+-binding site of the C2A domain, Munc13-4(C2B*) carries two 
analogous point mutations in the Ca2+-binding site of the C2B domain, and Munc13-
4(C2A*B*) carries these mutations in both C2 domains (Boswell et al., 2012). 
(b) Change in the number of Munc13-4-positive objects per 100 µm2 after histamine 
stimulation. Cells were transfected and stimulated as in (a). Means of n-fold changes 
over all cells from at least 5 independent experiments were tested for statistical 
significance by one-way ANOVA with Tukey’s test (ns, statistically not significant, **** 
p≤0.0001, as compared to the wildtype samples). Numbers of cells analyzed, n, were 
as follows: Munc13-4, n=33; Munc13-4(543-1090), n=27; Munc13-4(1-899), n=42; 
Munc13-4(285-917), n=14; Munc13-4, n=32; Munc13-4(C2A*), n=52; Munc13-
4(C2B*), n=35; Munc13-4(C2A*B*), n=35.  Means±SEM: 
3.5±0.3/1.3±0.03/1.2±0.02/1.2±0.02/ 2.8±0.1/1.8±0.1/1.5±0.1/1.2±0.02 /2.3±0.2. 
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Figure 8. Munc13-4 interacts with the S100A10 subunit of the AnxA2-S100A10 
complex. 
(a) Domain structures of Munc13-4 and S100A10. MUN, Munc13-homology domain.  
(b) S100A10 binds to both C2 domains of Munc13-4. In vitro binding assay with full-
length or truncated mutants of Munc13-4 and wild-type S100A10. Bacterially 
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expressed His6-Munc13-4 derivatives were immobilized on NiNTA and incubated 
with purified S100A10 (Input). After several washing steps, bound S100A10 was 
eluted as described in Materials and methods (Elution). Lysates of untransformed E. 
coli served as negative control. The amount of eluted S100A10 as percent of 
S100A10 input was quantified from at least three different expreriment and is given 
next to the respective mutant panel on the right. Values are means±SEM. 
(c) Two C-terminally truncated mutants of S100A10, S100A10(1-90) and S100A10(1-
84), do not bind Munc13-4. In vitro binding assay as described in (b) with 
immobilized full-length His6-Munc13-4 and the two S100A10 truncation mutants. 
Note that S100A10(1-90) which can still bind AnxA2(Kube et al., 1992) fails to 
interact with Munc13-4. 
(d) Co-immunoprecipitation of Munc13-4 and AnxA2-S100A10. Postnuclear HUVEC 
supernatants were incubated with dynabead-coupled antibodies against either 
Munc13-4 (IP Munc13-4) or rabbit IgGs as negative control (IP IgG). The starting 
material (Input) and the precipitated proteins were analyzed by SDS-PAGE (15% gel 
in upper, 10% gel in lower panels) and immunoblotting with antibodies against 
Munc13-4, S100A10 or AnxA2. 
(e) Relative amount of precipitated Munc13-4 and S100A10 in the 
immunoprecipitation experiments using either specific anti-Munc13-4 (IP) or control 
rabbit IgGs (IgG). Band intensities were calculated as percent of the input material 




Figure 9. Munc13-4 and S100A10 function together in histamine-induced 
secretion of VWF. 
(a, b) Histamine-induced recruitment of Munc13-4 to WPB fusion sites is decreased 
upon AnxA2-S100A10 depletion. HUVEC were tansfected for 48 h with VWF-GFP as 
WPB marker, Munc13-4-mKate and unspecific siControl RNAs or siRNAs targeting 
AnxA2-S100A10. Cells were stimulated with histamine at t=0 s, imaged by live-cell 
TIRF microscopy and individual WPB fusion sites were identified by a collapse of the 
VWF-GFP signal. Image stills were thresholded in ImageJ to create regions-of-
interest (ROIs) for Munc13-4-positive WPBs at WPB fusion sites and to compare 
mean fluorescence intensities of all ROIs shortly before and shortly after stimulation. 
Mean fluorescence intensity before stimulation was set to 1 and the increase after 
stimulation was measured as the n-fold change in mean fluorescence intensity. (a) 
Examples of Munc13-4-mKate mean fluorescence intensity recordings of individual 
WPBs from cells treated with siControl or siRNAs targeting AnxA2-S100A10, 
respectively. (b) Comparison of histamine-induced Munc13-4-mKate fluorescence 
intensity changes of individual WPBs in siControl and siAnxA2/siS100A10 treated 
cells at 2.5 s after stimulation. Mean n-fold changes from individual ROIs for Munc13-
4-mKate positive WPBs (a total of at least n=57 WPBs per condition from at least 
three independent experiments) were tested for statistical significance by Mann-
Whitney U test (** p≤0.01). 
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(c) ELISA-based VWF secretion assay. HUVEC were transfected for 48 h with 
unspecific siControl or siRNA targeting Munc13-4 (siMunc13-4) or S100A10 
(siS100A10), or siRNAs targeting both proteins in a double knockdown (siMunc13-
4/siS100A10). In each case, the amount of VWF secreted into the cell culture 
supernatant was measured by ELISA. Shown are means of four independent 
experiments that were tested for statistical significance by one-way ANOVA with 
Tukey’s test (** p≤0.01, *** p≤0.001, ****p≤0.0001 as related to the control sample). 
Differences between samples treated with specific siRNA were statistically not 
significant (ns). Bars represent mean±SEM. 
 
